返回
VISEN Pharmaceuticals（02561.HK）價格
02561.HK 股價走勢圖
VISEN PHARMA-B (02561.HK)
VISEN Pharmaceuticals
HK$33.8
-1.51%
$-0.52
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$34.42
開盤價
$34.32
當日範圍
$33.1 - $34.32
52週區間
$29.06 - $69.15
交易量
15.6K
平均成交量
32.8K
每股盈餘 (TTM)
-2.12
股息收益率
--
市值
$3.8B
什麼是 VISEN PHARMA-B？
VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.
